Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel J Bos

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Stroke|March 1, 2008
Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam StudyMichiel J Bos, Stephanie C E Schuit, Peter J Koudstaal, et al.
Archives of Internal Medicine|June 11, 2008
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of strokeMendel D M Haag, Michiel J Bos, Albert Hofman, et al.
Stroke|November 26, 2015
Role of Prestroke Vascular Pathology in Long-Term Prognosis After Stroke: The Rotterdam StudyMarileen L P Portegies, Michiel J Bos, Albert Hofman, et al.
Circulation|October 4, 2006
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam StudyMichiel J Bos, C Maarten A Schipper, Peter J Koudstaal, et al.
JAMA|December 27, 2007
Incidence and prognosis of transient neurological attacksMichiel J Bos, Marie Josee E van Rijn, Jacqueline C M Witteman, et al.
Stroke|December 16, 2014
Subjective memory complaints and the risk of strokeAyesha Sajjad, Saira Saeed Mirza, Marileen L P Portegies, et al.
BMC Medicine|July 22, 2015
The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam StudyRenée F A G de Bruijn, Michiel J Bos, Marileen L P Portegies, et al.
Thrombosis and Haemostasis|August 12, 2008
Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam StudyElim Y L Cheung, Michiel J Bos, Frank W G Leebeek, et al.
JAMA Neurology|February 19, 2014
Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam StudyDaniel Bos, Marileen L P Portegies, Aad van der Lugt, et al.
Stroke|November 4, 2006
Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular riskMarie Josee E van Rijn, Michiel J Bos, Mojgan Yazdanpanah, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Stroke|March 1, 2008
Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam StudyMichiel J Bos, Stephanie C E Schuit, Peter J Koudstaal, et al.
Archives of Internal Medicine|June 11, 2008
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of strokeMendel D M Haag, Michiel J Bos, Albert Hofman, et al.
Stroke|November 26, 2015
Role of Prestroke Vascular Pathology in Long-Term Prognosis After Stroke: The Rotterdam StudyMarileen L P Portegies, Michiel J Bos, Albert Hofman, et al.
Circulation|October 4, 2006
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam StudyMichiel J Bos, C Maarten A Schipper, Peter J Koudstaal, et al.
JAMA|December 27, 2007
Incidence and prognosis of transient neurological attacksMichiel J Bos, Marie Josee E van Rijn, Jacqueline C M Witteman, et al.
Stroke|December 16, 2014
Subjective memory complaints and the risk of strokeAyesha Sajjad, Saira Saeed Mirza, Marileen L P Portegies, et al.
BMC Medicine|July 22, 2015
The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam StudyRenée F A G de Bruijn, Michiel J Bos, Marileen L P Portegies, et al.
Thrombosis and Haemostasis|August 12, 2008
Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam StudyElim Y L Cheung, Michiel J Bos, Frank W G Leebeek, et al.
JAMA Neurology|February 19, 2014
Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam StudyDaniel Bos, Marileen L P Portegies, Aad van der Lugt, et al.
Stroke|November 4, 2006
Alpha-adducin polymorphism, atherosclerosis, and cardiovascular and cerebrovascular riskMarie Josee E van Rijn, Michiel J Bos, Mojgan Yazdanpanah, et al.
Pageof 3